Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD009528Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 diciembre 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Valerie Waters

    Correspondencia a: Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada

    [email protected]

  • Felix Ratjen

    Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada

Contributions of authors

Roles and responsibilities

TASK

WHO WILL UNDERTAKE THE TASK?

Protocol stage: draft the protocol

Valerie Waters

Review stage: select which trials to include (2 + 1 arbiter)

Valerie Waters and Felix Ratjen (+ Nikki Jahnke)

Review stage: extract data from trials (2 people)

Valerie Waters and Felix Ratjen

Review stage: enter data into RevMan

Valerie Waters

Review stage: carry out the analysis

Valerie Waters and Felix Ratjen

Review stage: interpret the analysis

Valerie Waters and Felix Ratjen

Review stage: draft the final review

Valerie Waters and Felix Ratjen

Update stage: update the review

Valerie Waters and Felix Ratjen

Declarations of interest

Both authors of this review are investigators in the current biofilm study funded by a grant from Innovotech Inc.

Version history

Published

Title

Stage

Authors

Version

2020 Jun 10

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Review

Sherie Smith, Valerie Waters, Nikki Jahnke, Felix Ratjen

https://doi.org/10.1002/14651858.CD009528.pub5

2017 Oct 05

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Review

Valerie Waters, Felix Ratjen

https://doi.org/10.1002/14651858.CD009528.pub4

2015 Mar 05

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Review

Valerie Waters, Felix Ratjen

https://doi.org/10.1002/14651858.CD009528.pub3

2012 Nov 14

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Review

Valerie Waters, Felix Ratjen

https://doi.org/10.1002/14651858.CD009528.pub2

2011 Dec 07

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Protocol

Valerie Waters, Felix Ratjen

https://doi.org/10.1002/14651858.CD009528

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.